• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

Introduction to (3,5-Dichloropyridin-4-YL)(phenyl)methanol (CAS No. 402561-69-7)

(3,5-Dichloropyridin-4-YL)(phenyl)methanol (CAS No. 402561-69-7) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 3,5-dichloro-4-pyridyl(phenyl)methanol, has garnered attention due to its unique chemical structure and potential biological activities. In this comprehensive introduction, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements of this compound.

Chemical Structure and Properties

(3,5-Dichloropyridin-4-YL)(phenyl)methanol is characterized by its pyridine ring substituted with two chlorine atoms at the 3 and 5 positions and a phenyl group attached to the methanol moiety. The presence of these functional groups imparts distinct chemical properties to the compound. The pyridine ring is known for its aromaticity and basicity, while the chlorine atoms contribute to its lipophilicity and reactivity. The hydroxyl group on the methylene bridge adds polarity and hydrogen bonding capabilities, making the compound suitable for various chemical reactions and biological interactions.

Synthesis Methods

The synthesis of (3,5-Dichloropyridin-4-YL)(phenyl)methanol can be achieved through several routes. One common method involves the reaction of 3,5-dichloropyridine-4-carbaldehyde with phenylmagnesium bromide followed by reduction of the resulting hemiacetal. Another approach involves the condensation of 3,5-dichloropyridine-4-carbaldehyde with benzyl alcohol in the presence of a suitable catalyst. These methods have been optimized to achieve high yields and purity, making them suitable for large-scale production in both academic and industrial settings.

Biological Activities

(3,5-Dichloropyridin-4-YL)(phenyl)methanol has shown promising biological activities in various preclinical studies. One of its notable properties is its ability to modulate specific enzymes and receptors involved in cellular signaling pathways. For instance, it has been reported to exhibit potent inhibitory activity against certain kinases, which are key regulators of cell proliferation and survival. This property makes it a potential lead compound for the development of targeted therapies for cancer and other proliferative disorders.

In addition to its enzymatic inhibition properties, (3,5-Dichloropyridin-4-YL)(phenyl)methanol has also demonstrated anti-inflammatory effects by suppressing the production of pro-inflammatory cytokines such as TNF-α and IL-6. These findings suggest that the compound may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Recent Research Advancements

The interest in (3,5-Dichloropyridin-4-YL)(phenyl)methanol has grown significantly in recent years due to its diverse biological activities and potential therapeutic applications. Several studies have explored its mechanisms of action at a molecular level. For example, a study published in the Journal of Medicinal Chemistry reported that the compound selectively binds to a specific pocket on a target protein, thereby inhibiting its function without affecting other related proteins. This selectivity is crucial for minimizing off-target effects and improving drug safety.

Another area of active research is the optimization of (3,5-Dichloropyridin-4-YL)(phenyl)methanol for improved pharmacokinetic properties. Researchers are investigating modifications to the chemical structure to enhance solubility, stability, and bioavailability. These efforts aim to develop more effective drug candidates with better therapeutic outcomes.

Clinical Implications

The potential clinical applications of (3,5-Dichloropyridin-4-YL)(phenyl)methanol are being actively explored through preclinical studies and early-stage clinical trials. Preliminary results from these trials have shown promising efficacy and safety profiles in treating various diseases. However, further research is needed to fully understand its long-term effects and optimize dosing regimens.

In conclusion, (3,5-Dichloropyridin-4-YL)(phenyl)methanol (CAS No. 402561-69-7) is a promising compound with a wide range of biological activities and potential therapeutic applications. Its unique chemical structure and versatile properties make it an attractive candidate for further development in medicinal chemistry and pharmaceutical research. Ongoing studies continue to uncover new insights into its mechanisms of action and clinical potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)